Please select the eligibility criteria that correspond to the clinical trial below.
Title: High Blood Pressure Care for Korean Americans
Brief Summary: The primary objective of the proposed clinical trials is to compare the differential reduction in blood pressure in underserved hypertensive adult Korean American. The study is designed to test the effectiveness of a comprehensive self-help intervention program.


Options:
A: Inclusion Criteria:

PHQ9 Score \> or = to 12

Exclusion Criteria:

A diagnosis of schizophrenia, current suicide ideation, recent bereavement, or receiving specialty mental health treatment
B: Inclusion Criteria:

* Self-identified as first-generation Korean American
* Age 40 to 65 years of age
* SBP≥140 or DBP≥90mmHg on HBP medication
* resident of Greater Baltimore census tracts
* Written consent to participate in the screening/eligibility visit
* SBP≥140 or DBP≥90mmHg at the KRC HBP verification visit
* Written consent to participate in the clinical trial:agreeing to participate in study data collection procedures, receiving HBP education, using HBPMT, and permitting contact with their own medical care provider.

Exclusion Criteria:

* Acute and/or terminal condition precluding participation such as terminal cancer or acute myocardial infarction
* Psychiatric diagnosis precluding participation such as schizophrenia and cognitive impairment measured by self-report, chart review, or clinical assessment.
C: Inclusion Criteria:

* Age ≥ 55 years (from the day of the 55. birthday inclusive)
* Diagnosis of primary (essential) hypertension (I10 according to International Classification of Diseases (ICD-10))
* Filling of blood pressure-lowering prescription(s) at trial recruitment (Visit 1)
* Duration of antihypertensive drug treatment for at least 1 year without any discontinuation
* Ownership of a mobile phone for personal use with the ability to open and read SMS
* Understanding of Slovak language on native-speaker level
* Informed consent for participation in the clinical trial and personally signed Informed Consent Form

Exclusion Criteria:

Exclusion criteria assessed prior to patient enrolment (by trial pharmacists):

* Planned hospitalisation during the trial period (3 months)
* Biological impairment affecting the ability to read the SMS (e.g. loss of vision, visual field cuts, aphasia)
* Living in the same household with another trial participant
* Participation in another clinical trial

Exclusion criteria assessed after patient enrolment (by trial pharmacists and project leader):

* Hospitalisation during the trial period
* Patient informs he/she won't be able to participate in the trial
* Withdrawal of Informed Consent
D: Inclusion Criteria:

* Patients who have successfully completed the Partners Connected Cardiac Care Program (CCCP)
* Take at least 3 and no more than 10 different daily medications (including both prescription and non-prescription/over the counter medications) to treat Heart Failure (HF) and other comorbid disorders.
* Take medications no more than 4 specified times each day (i.e. morning, afternoon, early evening, bedtime).
* The patient must be able to open a pill bottle independently.
* The patient must be able to sort and manage their own medications.
* Hospitalization within the last 24 months.
* Have a telephone or cell phone.
* Live in the greater Boston area.
* The patients must speak, read and write English.
* The patients must not be either vision or hearing impaired (i.e., unable to hear an alarm similar to a clock alarm or oven alarm).
* Patient must have an Massachusetts General Hospital (MGH) affiliated care provider.

Exclusion Criteria:

* Dementia or other conditions precluding the participant from providing informed consent or from learning to use the MedSentry pillbox.
* Home environment unsuitable for the MedSentry pillbox and other installed equipment.
* Awaiting revascularization, cardiac resynchronization or heart transplant.
* Patients with a coexisting terminal illness like cancer or Chronic Renal Failure (CRF) requiring dialysis.

Answer: B